IP Verse

Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione

Patent No. EP3756650 (titled "Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione") was filed by Amgen Europe on Dec 26, 2012. The application was issued on Aug 20, 2025.

Patent Summary

Pharmaceutical compositions comprising (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione (Compound A) for treating various diseases and disorders, including cancer, pain, inflammatory diseases, and ocular neovascular diseases. The compositions comprise Compound A in combination with fillers, disintegrants, and lubricants, and may be formulated as tablets or capsules. The compositions exhibit advantageous physical and pharmacological properties, including fast disintegration, low friability, and stability.

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
COOKEMar 18, 2026ELKINGTON AND FIFE
BRAND MURRAY FULLERJan 12, 2026BRAND MURRAY FULLER
HAMM & WITTKOPPDec 19, 2025HAMM & WITTKOPP
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBDec 8, 2025TER MEER STEINMEISTER & PARTNER
CAMULONOct 24, 2025REDDIE & GROSE
ELKINGTON AND FIFEOct 1, 2025ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3756650

AMGEN EUROPE
Application Number
EP20172615A
Filing Date
Dec 26, 2012
Status
Granted And Under Opposition
Jul 18, 2025
Publication Date
Aug 20, 2025
External Links
Slate, Register , Google Patents